Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA

January 8, 2024

https://www.globenewswire.com/news-release/2024/01/08/2805335/0/en/Vivos-Therapeutics-Sees-Positive-Preliminary-Metrics-Following-Unprecedented-FDA-510-k-Clearance-of-the-Company-s-Proprietary-Oral-Medical-Devices-to-Treat-Severe-OSA.html

New Dentist Inquiries Jumped 600% and
Signed Dentist Enrollment Contracts up 38% Sequentially Over Q3

CARE Oral Medical Device Unit Orders Increased 26% Following FDA Clearance

Read more at globenewswire.com

Related news for (VVOS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.